FDA Import Refusal 112-7398660-8/1/1 — Glaxosmithkline
The FDA refused shipment 112-7398660-8/1/1 from Glaxosmithkline (United Kingdom) on Jan 13, 2012. The refused product falls under Drugs and Biologics — LAMOTRIGINE (ANTI-CONVULSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 13, 2012
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61MCB38 LAMOTRIGINE (ANTI-CONVULSANT)
- Charges
- 75